Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53

[1]  A. Fersht,et al.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain , 1998, The EMBO journal.

[2]  T. Oas,et al.  Protein folding dynamics: quantitative comparison between theory and experiment. , 1998, Biochemistry.

[3]  J. Udgaonkar,et al.  Multiple intermediates and transition states during protein unfolding , 1997, Nature Structural Biology.

[4]  E. Stavridi,et al.  Hydrophobic side‐chain size is a determinant of the three‐dimensional structure of the p53 oligomerization domain , 1997, The EMBO journal.

[5]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[6]  A. Fersht.  Nucleation mechanisms in protein folding. , 1997, Current opinion in structural biology.

[7]  M. Bycroft,et al.  The dimeric DNA binding domain of the human papillomavirus E2 protein folds through a monomeric intermediate which cannot be native-like , 1996, Nature Structural Biology.

[8]  R. Sauer,et al.  Nonlinear free energy relationships in Arc repressor unfolding imply the existence of unstable, native-like folding intermediates. , 1996, Biochemistry.

[9]  C. Arrowsmith,et al.  New insights into p53 function from structural studies. , 1996, Oncogene.

[10]  A. Fersht,et al.  The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. , 1995, Journal of molecular biology.

[11]  R. Sauer,et al.  P22 Arc repressor: transition state properties inferred from mutational effects on the rates of protein unfolding and refolding. , 1995, Biochemistry.

[12]  C. Matthews,et al.  Probing the folding mechanism of a leucine zipper peptide by stopped-flow circular dichroism spectroscopy. , 1995, Biochemistry.

[13]  C. Arrowsmith,et al.  Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. , 1995, Biochemistry.

[14]  G. Marius Clore,et al.  Refined solution structure of the oligomerization domain of the tumour suppressor p53 , 1995, Nature Structural Biology.

[15]  A. Baici,et al.  Kinetics of folding of leucine zipper domains. , 1995, Biochemistry.

[16]  N. Pavletich,et al.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms , 1995, Science.

[17]  A. Fersht,et al.  Characterizing transition states in protein folding: an essential step in the puzzle. , 1995, Current opinion in structural biology.

[18]  C. Arrowsmith,et al.  Solution structure of the tetrameric minimum transforming domain of p53 , 1995, Nature Structural Biology.

[19]  K. Neet,et al.  Conformational stability of dimeric proteins: Quantitative studies by equilibrium denaturation , 1994, Protein science : a publication of the Protein Society.

[20]  A. Baici,et al.  Mechanism of assembly of a leucine zipper domain , 1994 .

[21]  Luis Serrano,et al.  Elucidating the folding problem of helical peptides using empirical parameters , 1994, Nature Structural Biology.

[22]  R. Sauer,et al.  P22 Arc repressor: folding kinetics of a single-domain, dimeric protein. , 1994, Biochemistry.

[23]  A. Fersht,et al.  The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. , 1992, Journal of molecular biology.

[24]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[25]  Matthews Cr,et al.  Folding and stability of trp aporepressor from Escherichia coli. , 1990 .

[26]  M. Gittelman,et al.  Folding and stability of trp aporepressor from Escherichia coli. , 1990, Biochemistry.

[27]  R. Jaenicke,et al.  Folding and association of proteins. , 1982, Biophysics of structure and mechanism.

[28]  C. Tanford.  Protein denaturation. , 1968, Advances in protein chemistry.